Results 161 to 170 of about 95,141 (285)
Autoantibodies and Their Role in Scleroderma Clinical Care [PDF]
Robyn T. Domsic, Thomas A. Medsger
openalex +1 more source
The HAQ disability index in scleroderma trials [PDF]
Sindhu R. Johnson
openalex +1 more source
OP0144 Intravenous versus oral cyclophosphamide (CYC) for the treatment of interstitial lung involvement (ILD) and skin involvement in systemic sclerosis (SSC): safety and efficacy evaluation in a large multi-centre scleroderma cohort [PDF]
Cosimo Bruni +7 more
openalex +1 more source
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
Pei‐Suen Tsou +7 more
openalex +2 more sources
Combination of lipoatrophic diabetes mellitus with systemic scleroderma and phenylketonuria
Г. Н. Светлова +3 more
openalex +2 more sources
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast. [PDF]
Barnawi G +4 more
europepmc +1 more source
FRI0490 Sensitivity Testing of New Systemic Scleroderma Criteria in the Russian Patient Population [PDF]
O. Koneva +3 more
openalex +1 more source

